Market Tracker

07/24 8:21am ET

Vanguard Health Care Index Fund ETF Shares (VHT)

150.56
Delayed Data
As of Jul 21
 -0.07 / -0.05%
Today’s Change
120.38
Today|||52-Week Range
151.23
+18.77%
Year-to-Date

Investment Objective

The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.

J&J Brightens Outlook: Healthcare ETFs in Focus
Jul 19 / Zacks.com - Paid Partner Content
 

Performance

1 month+1.53% 3 years+12.11%
3 months+10.65% 5 years+18.45%
1 year+11.94% Since inception+9.91%
Data through 07/22/2017

Quote Details

Previous close$150.63
Open day’s range150.29 – 151.20
Net asset value (NAV)150.53 (07/21/2017)
Daily volume143,510
Average volume (3 months)176,741
Data as of 07/21/2017

Peer Comparisonvs. Health ETFs

 VHTCategory
Performance 5-yr return+18.45%+17.39%
Expense Gross exp ratio0.10%1.33%
Risk 5 year sharpe ratio1.391.14
Net assets$7.6B$3.0B
Average market cap$52.2B$30.8B
Average P/E24.124.5
Dividend / Share--0.30%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 97.05%
Hardware 1.62%
Business service 0.22%
Financial service 0.05%
Consumer service 0.02%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson10.08%
PFE Pfizer5.62%
UNH UnitedHealth5.02%
MRK Merck4.96%
AMGN Amgen3.56%
MDT Medtronic PLC3.42%
ABBV AbbVie3.25%
CELG Celgene2.84%
BMY Bristol-Myers Squibb2.62%
GILD Gilead Sciences2.60%